Have a personal or library account? Click to login
Evaluation of the BioFire® FilmArray® Pneumonia plus Panel for Detecting Bacterial Etiological Agents of Lower Respiratory Tract Infections in an Oncologic Hospital. Comparison with Conventional Culture Method Cover

Evaluation of the BioFire® FilmArray® Pneumonia plus Panel for Detecting Bacterial Etiological Agents of Lower Respiratory Tract Infections in an Oncologic Hospital. Comparison with Conventional Culture Method

Open Access
|Dec 2023

References

  1. Alnimr A. Antimicrobial resistance in ventilator-associated pneumonia: Predictive microbiology and evidence-based therapy. Infect Dis Ther. 2023 Jun;12(6):1527–1552. https://doi.org/10.1007/s40121-023-00820-2
  2. Azoulay E, Pickkers P, Soares M, Perner A, Rello J, Bauer PR, van de Louw A, Hemelaar P, Lemiale V, Taccone FS, et al.; Efraim investigators and the Nine-I study group. Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort study. Intensive Care Med. 2017 Dec; 43(12):1808–1819. https://doi.org/10.1007/s00134-017-4947-1
  3. Azoulay E, Russell L, Van de Louw A, Metaxa V, Bauer P, Povoa P, Montero JG, Loeches IM, Mehta S, Puxty K, et al; Nine-i Investigators. Diagnosis of severe respiratory infections in immunocompromised patients. Intensive Care Med. 2020 Feb;46(2):298–314. https://doi.org/10.1007/s00134-019-05906-5
  4. Bai L, Yang W, Li Y. Clinical and laboratory diagnosis of Legionella Pneumonia. Diagnostics. 2023 Jan 12;13(2):280. https://doi.org/10.3390/diagnostics13020280
  5. Black AD. Non-infectious mimics of community-acquired pneumonia. Pneumonia. 2016 Apr;8:2. https://doi.org/10.1186/s41479-016-0002-1
  6. Buchan BW, Windham S, Balada-Llasat JM, Leber A, Harrington A, Relich R, Murphy C, Dien Bard J, Naccache S, Ronen S, et al. Practical comparison of the BioFire FilmArray Pneumonia panel to routine diagnostic methods and potential impact on antimicrobial stewardship in adult hospitalized patients with lower respiratory tract infections. J Clin Microbiol. 2020 Jun;58(7):e00135-20. https://doi.org/10.1128/JCM.00135-20
  7. Clark RB, Lewinski MA, Loeffelholz MJ, Tibbetts RJ. Cummitech 31A, Verification and validation of procedures in the clinical microbiology laboratory. Washington (USA): ASM Press; 2009.
  8. Conway Morris A. Management of pneumonia in intensive care. J Emerg Crit Care Med. 2018 Dec;2:10. https://doi.org/10.21037/jeccm.2018.11.06
  9. Cristovam E, Almeida D, Caldeira D, Ferreira JJ, Marques T. Accuracy of diagnostic tests for Legionnaires’ disease: A systematic review. J Med Microbiol. 2017 Apr;66(4):485–489. https://doi.org/10.1099/jmm.0.000454
  10. Edin A, Eilers H, Allard A. Evaluation of the Biofire Filmarray Pneumonia panel plus for lower respiratory tract infections. Infect Dis. 2020 Jul;52(7):479–488. https://doi.org/10.1080/23744235.2020.1755053
  11. EUCAST. The European Committee on Antimicrobial Susceptibility Testing. Antimicrobial susceptibility testing EUCAST disk diffusion method. Version 11.0. Stockholm (Sweden): The European Committee on Antimicrobial Susceptibility Testing; 2023a [cited 2023 Mar 29]. Available from https://www.eucast.org/ast_of_bacteria/disk_diffusion_methodology
  12. EUCAST. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 13.0. Stockholm (Sweden): The European Committee on Antimicrobial Susceptibility Testing; 2023b [cited 2023 Mar 29]. Available from: https://www.eucast.org/clinical_breakpoints
  13. Fernández-Cruz A, Ortega L, García G, Gallego I, Álvarez-Uría A, Chamorro-de-Vega E, García-López JJ, González-Del-Val R, Martín-Rabadán P, Rodríguez C, et al. Etiology and prognosis of pneumonia in patients with solid tumors: A prospective cohort of hospitalized cases. Oncologist. 2020 May;25(5):e861-e869 https://doi.org/10.1634/theoncologist.2019-0031
  14. Ginocchio CC, Garcia-Mondragon C, Mauerhofer B, Rindlisbacher C; and the EME Evaluation Program Collaborative. Multinational evaluation of the BioFire® FilmArray® Pneumonia plus Panel as compared to standard of care testing. Eur J Clin Microbiol Infect Dis. 2021 Aug;40(8):1609–1622. https://doi.org/10.1007/s10096-021-04195-5
  15. Han XY, Ihegword A, Evans SE, Zhang J, Li L, Cao H, Tarrand JJ, El-Kweifi O. Microbiological and clinical studies of legionellosis in 33 patients with cancer. J Clin Microbiol. 2015 Jul;53(7):2180–2187. https://doi.org/10.1128/JCM.00380-15
  16. Hryniewicz W, Albrecht P, Radzikowski A. [Rekomendacje postq-powania w pozaszpitalnych zakazeniach ukladu oddechowego] (in Polish). Warsaw (Poland): Narodowy Instytut Leków; 2016.
  17. ICNARC. Intensive Care National Audit and Research Centre. Key statistics from the Case Mix Programme - adult, general critical care units. 1 April 2015 to 31 March 2016. London (UK): Intensive Care National Audit and Research Centre; 2017 [cited 2023 Apr 12]. Available from: http://www.icnarc.org
  18. Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM, Reed C, Grijalva CG, Anderson EJ, Courtney DM, et al.; CDC EPIC Study Team. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med. 2015 Jul;373(5):415–427. https://doi.org/10.1056/NEJMoa1500245
  19. Jitmuang A, Puttinad S, Hemvimol S, Pansasiri S, Horthongkham N. A multiplex pneumonia panel for diagnosis of hospital-acquired and ventilator-associated pneumonia in the era of emerging antimicrobial resistance. Front Cell Infect Microbiol. 2022 Oct;12:77320. https://doi.org/10.3389/fcimb.2022.977320
  20. Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, Napolitano LM, O’Grady NP, Bartlett JG, Carratalà J, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016 Sep;63(5):e61-e111. https://doi.org/10.1093/cid/ciw353
  21. Kamel NA, Alshahrani MY, Aboshanab KM, El Borhamy MI. Evaluation of the BioFire FilmArray Pneumonia Panel Plus to the conventional diagnostic methods in determining the microbiological etiology of hospital-acquired pneumonia. Biology. 2022 Feb;11(3):377. https://doi.org/10.3390/biology11030377
  22. Kumar ST, Yassin A, Bhowmick T, Dixit D. Recommendations from the 2016 guidelines for the management of adults with hospital-acquired or ventilator-associated pneumonia. PT. 2017 Dec; 42(12):767–772.
  23. Leoni D, Encina B, Rello J. Managing the oncologic patient with suspected pneumonia in the intensive care unit. Expert Rev Anti Infect Ther. 2016 Oct;14(10):943–960. https://doi.org/10.1080/14787210.2016.1228453
  24. Latgé JP, Chamilos G. Aspergillus fumigatus and aspergillosis in 2019. Clin Microbiol Rev. 2019 Nov;33(1):e00140-18. https://doi.org/10.1128/CMR.00140-18
  25. Murphy CN, Fowler R, Balada-Llasat JM, Carroll A, Stone H, Akerele O, Buchan B, Windham S, Hopp A, Ronen S, et al. Multicenter evaluation of the BioFire FilmArray Pneumonia/Pneumonia Plus Panel for detection and quantification of agents of lower respiratory tract infection. J Clin Microbiol. 2020 Jun;58(7):e00128-20. https://doi.org/10.1128/JCM.00128-20
  26. Murphy T, Schwedock J, Nguyen K, Mills A, Jones D. Evaluation of PDA Technical Report No 33. Statistical testing recommendations for a rapid microbiological method case study. PDA J Pharm Sci Technol. 2015 Jul-Aug;69(4):526–539. https://doi.org/10.5731/pdajpst.2015.01062
  27. Nauclér P, Huttner A, van Werkhoven CH, Singer M, Tattevin P, Einav S, Tangdén T. Impact of time to antibiotic therapy on clinical outcome in patients with bacterial infections in the emergency department: implications for antimicrobial stewardship. Clin Microbiol Infect. 2021 Feb;27(2):175–181. https://doi.org/10.1016/j.cmi.2020.02.032
  28. PDA. Evaluation, validation and implementation of new microbiological testing methods. Technical Report No. 33. Bethesda (USA): Parenteral Drug Association; 2000.
  29. Parody R, Rabella N, Martino R, Otegui M, del Cuerpo M, Coll P, Sierra J. Upper and lower respiratory tract infections by human enterovirus and rhinovirus in adult patients with hematological malignancies. Am J Hematol. 2007 Sep;82(9):807–811. https://doi.org/10.1002/ajh.20974
  30. Ren J, Kang JB, Ma YP, Zhang JH, Dong CX, Kang JM, Zhang RJ, Wang MF, Ge XY, Yang LH. [Pathogen distribution and antimicrobial resistance among lower respiratory tract infections in patients with hematological malignancies] (in Chinese). Zhonghua Nei Ke Za Zhi. 2021 Oct 1;60(10):875–879. https://doi.org/10.3760/cmaj.cn112138-20201228-01056
  31. Rodríguez-Baño J, Gutiérrez-Gutiérrez B, Machuca I, Pascual A. Treatment of infections caused by extended-spectrum-beta-lacta-mase-, AmpC-, and carbapenemase-producing Enterobacteriaceae. Clin Microbiol Rev. 2018 Feb;31(2):e00079-17. https://doi.org/10.1128/CMR.00079-17
  32. Rolston KV. The spectrum of pulmonary infections in cancer patients. Curr Opin Oncol. 2001 Jul;13(4):218–223. https://doi.org/10.1097/00001622-200107000-00002
  33. Rolston KV. Infections in cancer patients with solid tumors: A review. Infect Dis Ther. 2017 Mar;6(1):69–83. https://doi.org/10.1007/s40121-017-0146-1
  34. Roquilly A, Torres A, Villadangos JA, Netea MG, Dickson R, Becher B, Asehnoune K. Pathophysiological role of respiratory dysbiosis in hospital-acquired pneumonia. Lancet Respir Med. 2019 Aug;7(8):710–720. https://doi.org/10.1016/S2213-2600(19)30140-7
  35. Schmiedel Y, Zimmerli S. Common invasive fungal diseases: an overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia. Swiss Med Wkly. 2016 Feb;146:w14281. https://doi.org/10.4414/smw.2016.14281
  36. Tabatabai J, Schnitzler P, Prifert C, Schiller M, Weissbrich B, von Lilienfeld-Toal M, Teschner D, Jordan K, Müller-Tidow C, Egerer G, et al. Parainfluenza virus infections in patients with hematological malignancies or stem cell transplantation: Analysis of clinical characteristics, nosocomial transmission and viral shedding. PLoS One. 2022 Jul;17(7):e0271756. https://doi.org/10.1371/journal.pone.0271756
  37. Torres A, Lee N, Cilloniz C, Vila J, Van der Eerden M. Laboratory diagnosis of pneumonia in the molecular age. Eur Respir J. 2016 Dec;48(6):1764–1778. https://doi.org/10.1183/13993003.01144-2016
  38. Watkins RR. Using precision medicine for the diagnosis and treatment of viral pneumonia. Adv Ther. 2022 Jul;39(7):3061–3071. https://doi.org/10.1007/s12325-022-02180-8
  39. Wong JL, Evans SE. Bacterial pneumonia in patients with cancer: Novel risk factors and management. Clin Chest Med. 2017 Jun; 38(2):263–277. https://doi.org/10.1016/j.ccm.2016.12.005
DOI: https://doi.org/10.33073/pjm-2023-035 | Journal eISSN: 2544-4646 | Journal ISSN: 1733-1331
Language: English
Page range: 391 - 398
Submitted on: May 26, 2023
|
Accepted on: Aug 20, 2023
|
Published on: Dec 16, 2023
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2023 Maria Teresa Szymankiewicz, Anna Szczepanska, Elzbieta Stefaniuk, published by Polish Society of Microbiologists
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.